The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

被引：40
|
作者：
de la Torre, Beatriz G. [1 ]
Albericio, Fernando [2 ,3 ]
机构：
[1] Univ KwaZulu Natal, Coll Hlth Sci, KRISP, ZA-4001 Durban, South Africa
[2] Univ KwaZulu Natal, Sch Chem & Phys, ZA-4001 Durban, South Africa
[3] Univ Barcelona, Dept Organ Chem, Networking Ctr Bioengn Biomat & Nanomed, CIBER BBN, E-08028 Barcelona, Spain
来源：
MOLECULES | 2018年 / 23卷 / 03期
基金：
新加坡国家研究基金会;
关键词：
drug discovery; API; peptide; biologics; small molecules; chemical entities;
D O I：
10.3390/molecules23030533
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
This is an analysis from a chemical point of view of the 46 drugs (34 New Chemical Entities and 12 Biologics) approved by the FDA during 2017. The drugs included in the 2017 "harvest" have been classified on the basis of their chemical structure: biologics (antibodies and proteins); peptides; amino acids and natural products; drug combinations; and small molecules.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2024, 29 (03):
  • [2] The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G. G.
    Albericio, Fernando
    [J]. MOLECULES, 2023, 28 (03):
  • [3] The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2020, 25 (03):
  • [4] The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2022, 27 (03):
  • [5] The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2019, 24 (04):
  • [6] The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2021, 26 (03):
  • [7] The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type
    de la Torre, Beatriz G.
    Albericio, Fernando
    [J]. MOLECULES, 2017, 22 (03)
  • [8] 2017 FDA drug approvals
    Mullard A.
    [J]. Nature Reviews Drug Discovery, 2018, 17 (2) : 81 - 85
  • [9] Erratum: 2017 FDA drug approvals
    Asher Mullard
    [J]. Nature Reviews Drug Discovery, 2018, 17 (2) : 150 - 150
  • [10] FDA Drug Approvals Hit Record Levels in 2017
    Challener, Cynthia A.
    [J]. BIOPHARM INTERNATIONAL, 2018, 31 (01) : 12 - 14
12345